DOJOLVI Trademark

Trademark Overview

On Friday, March 22, 2019, a trademark application was filed for DOJOLVI with the United States Patent and Trademark Office. The USPTO has given the DOJOLVI trademark a serial number of 88352451. The federal status of this trademark filing is REGISTERED as of Tuesday, October 13, 2020. This trademark is owned by Ultragenyx Pharmaceutical Inc.. The DOJOLVI trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FAOD)
dojolvi

General Information

Serial Number88352451
Word MarkDOJOLVI
Filing DateFriday, March 22, 2019
Status700 - REGISTERED
Status DateTuesday, October 13, 2020
Registration Number6176000
Registration DateTuesday, October 13, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2019

Trademark Statements

Goods and Servicespharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FAOD)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 10, 2019
Primary Code005
First Use Anywhere DateTuesday, July 21, 2020
First Use In Commerce DateTuesday, July 21, 2020

Trademark Owner History

Party NameUltragenyx Pharmaceutical Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameUltragenyx Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameUltragenyx Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events

Event DateEvent Description
Tuesday, March 26, 2019NEW APPLICATION ENTERED
Wednesday, April 10, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 3, 2019ASSIGNED TO EXAMINER
Monday, June 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 19, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 9, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 14, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, August 27, 2019ASSIGNED TO PETITION STAFF
Thursday, August 29, 2019POST PUBLICATION AMENDMENT - ENTERED
Tuesday, September 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 20, 2019SOU TEAS EXTENSION RECEIVED
Friday, December 20, 2019SOU EXTENSION 1 FILED
Friday, December 20, 2019SOU EXTENSION 1 GRANTED
Tuesday, December 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 25, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, August 25, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, September 8, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 25, 2020SOU EXTENSION 2 FILED
Wednesday, September 9, 2020SOU EXTENSION 2 GRANTED
Tuesday, August 25, 2020USE AMENDMENT FILED
Wednesday, September 9, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 9, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, September 10, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, September 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 13, 2020REGISTERED-PRINCIPAL REGISTER
Friday, August 2, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 2, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 2, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 2, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 13, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 21, 2025TEAS SECTION 8 & 15 RECEIVED

Related Keywords

dojolvi disorders treating pharmaceuticals chain long fatty oxidation faod enzyme acid